Champions Oncology Inc (CSBR) Insider Trading
- $7,080,416.50
- $5,868,066.61
- Jan. 12, 2024
- Daniel Newman Mendelson
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Jan. 12, 2024 | Director | 1,000 | $6.50 | Buy | $6,500.00 | |
| Jan. 10, 2024 | Director | 2,944 | $6.31 | Buy | $18,576.64 | |
| Jan. 8, 2024 | Director | 1,000 | $6.15 | Buy | $6,150.00 | |
| Jan. 5, 2024 | Director | 2,000 | $6.09 | Buy | $12,180.00 | |
| Jan. 3, 2024 | Director | 500 | $5.83 | Buy | $2,915.00 | |
| Dec. 21, 2023 | Director | 2,500 | $4.92 | Buy | $12,300.00 | |
| Dec. 19, 2023 | Director | 5,000 | $4.75 | Buy | $23,750.00 | |
| Oct. 10, 2023 | Director | 1,100 | $6.41 | Buy | $7,051.00 | |
| Oct. 5, 2023 | Director | 2,000 | $6.47 | Buy | $12,940.00 | |
| Oct. 3, 2023 | Director | 2,500 | $6.30 | Buy | $15,750.00 | |
| Sept. 26, 2023 | Director | 5,000 | $5.65 | Buy | $28,250.00 | |
| Sept. 21, 2023 | Director | 5,000 | $5.51 | Buy | $27,550.00 | |
| Sept. 19, 2023 | Director | 5,000 | $5.28 | Buy | $26,400.00 | |
| March 17, 2023 | CEO | 12,382 | $4.04 | Buy | $50,023.28 | |
| Dec. 16, 2020 | Director | 31,443 | $11.35 | Sell | $356,878.05 | |
| March 26, 2020 | Director | 1,220 | $5.91 | Buy | $7,210.20 | |
| March 24, 2020 | CEO | 75 | $5.25 | Sell | $393.75 | |
| March 24, 2020 | Director | 26 | $5.50 | Buy | $143.00 | |
| March 20, 2020 | CEO | 75 | $4.75 | Buy | $356.25 | |
| March 6, 2020 | Major Shareholder | 708,155 | $6.99 | Sell | $4,950,003.45 | |
| Dec. 19, 2018 | CEO | 20,000 | $7.44 | Buy | $148,800.00 | |
| Nov. 6, 2018 | Director | 5,000 | $13.75 | Sell | $68,750.00 | |
| Oct. 1, 2018 | Director | 22,535 | $17.02 | Sell | $383,545.70 | |
| Sept. 20, 2018 | Director | 8,333 | $13.02 | Sell | $108,495.66 | |
| March 27, 2018 | CEO | 4,535 | $3.59 | Buy | $16,280.65 | |
| March 22, 2018 | CEO | 260 | $3.49 | Buy | $907.40 | |
| Oct. 21, 2016 | President | 30,000 | $1.66 | Buy | $49,800.00 | |
| Oct. 19, 2016 | President | 10,000 | $1.70 | Buy | $17,000.00 | |
| Oct. 18, 2016 | CEO | 2,000 | $1.70 | Buy | $3,400.00 | |
| Oct. 14, 2016 | President | 10,305 | $1.66 | Buy | $17,106.30 | |
| Oct. 14, 2016 | CEO | 7,300 | $1.67 | Buy | $12,191.00 | |
| Oct. 13, 2016 | President | 29,695 | $1.67 | Buy | $49,590.65 | |
| Oct. 10, 2016 | President | 9,537 | $1.66 | Buy | $15,831.42 | |
| Oct. 7, 2016 | CEO | 8,202 | $1.63 | Buy | $13,369.26 | |
| Sept. 23, 2016 | CEO | 33 | $1.65 | Buy | $54.45 | |
| Sept. 21, 2016 | CEO | 5,000 | $1.66 | Buy | $8,300.00 | |
| Sept. 20, 2016 | President | 3,000 | $1.58 | Buy | $4,740.00 | |
| March 11, 2015 | Major Shareholder | 6,250,000 | $0.40 | Buy | $2,500,000.00 | |
| March 20, 2014 | Director | 100,000 | $1.08 | Buy | $108,000.00 | |
| March 19, 2014 | President | 100,000 | $1.07 | Buy | $107,000.00 | |
| Jan. 28, 2013 | President | 500,000 | $0.50 | Buy | $250,000.00 | |
| Jan. 28, 2013 | Major Shareholder | 7,000,000 | $0.50 | Buy | $3,500,000.00 |
Insiders are both buying and selling Champions Oncology Inc stock.
The insider traders at Champions Oncology Inc are: Daniel Newman Mendelson, Ronnie Morris, Joel Ackerman, Michael Maurice Brown, Enterprise Associates 14 New, and Philip P. Breitfeld
The most active insider trader at Champions Oncology Inc is Daniel Newman Mendelson with 18 trades.
Enterprise Associates 14 New has sold the most Champions Oncology Inc stock with a total value of $9,900,006.90.
Michael Maurice Brown has bought the most Champions Oncology Inc stock with a total value of $8,500,000.00.
The most recent insider trade for Champions Oncology Inc was on Jan. 12, 2024.
The single biggest insider buy for Champions Oncology Inc was from Michael Maurice Brown with a total value of $3,500,000.00 on Jan. 28, 2013.
The single biggest insider sell for Champions Oncology Inc was from Enterprise Associates 14 New with a total value of $4,950,003.45 on March 6, 2020.